Pharmaceutical company Strides Acrolab has announced receipt of two ANDA approvals for Sterile vancomycin in HCL USP 500mg and 1g per vial and sterile Vancomycin HCI USP 5g per vial pharmacy bulk package.

The products are licensed to Akorn-Strides,LLC, which is a joint venture that was formed in 2004 by Akorn Inc. and Strides Arcolab Limited.

The primary mission for the joint venture is to develop liquid, lyophilized and dry powder formulations of generic injectable products targeting several therapeutic markets with a major focus on anti-infectives, analgesics and central nervous system medicines.